1. Home
  2. AMPL vs XNCR Comparison

AMPL vs XNCR Comparison

Compare AMPL & XNCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Amplitude Inc.

AMPL

Amplitude Inc.

N/A

Current Price

$17.41

Market Cap

2.2B

Sector

Technology

ML Signal

N/A

Logo Xencor Inc.

XNCR

Xencor Inc.

N/A

Current Price

$37.50

Market Cap

2.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
AMPL
XNCR
Founded
2012
1997
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
2.0B
IPO Year
2021
2013

Fundamental Metrics

Financial Performance
Metric
AMPL
XNCR
Price
$17.41
$37.50
Analyst Decision
Buy
Buy
Analyst Count
11
14
Target Price
$21.27
★ $42.50
AVG Volume (30 Days)
★ 1.9M
1.6M
Earning Date
11-04-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
11.84
★ 65.36
EPS
★ N/A
N/A
Revenue
★ $343,214,000.00
$125,576,000.00
Revenue This Year
$21.64
$57.39
Revenue Next Year
$16.99
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 14.68
13.65
52 Week Low
$5.51
$10.38
52 Week High
$18.85
$40.60

Technical Indicators

Market Signals
Indicator
AMPL
XNCR
Relative Strength Index (RSI) 60.76 69.59
Support Level $15.62 $22.80
Resistance Level $17.84 N/A
Average True Range (ATR) 0.91 2.07
MACD -0.08 0.74
Stochastic Oscillator 54.61 75.23

Price Performance

Historical Comparison
AMPL
XNCR

About AMPL Amplitude Inc.

Amplitude Inc is a Software company that provides a Digital Analytics Platform that helps companies analyze their customer behavior within digital products. The Company delivers its application over the Internet as a subscription service using a software-as-a-service (SaaS) model and also it offers customer support related to initial implementation setup, ongoing support services, and application training. The company generates revenue through selling subscriptions to the platform. The company derives a majority of its revenue from the United States, and also has its presence in Internationally.

About XNCR Xencor Inc.

Xencor Inc is a clinical-stage biopharmaceutical company focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases. The company uses its XmAb technology platform to create antibody product candidates. Its pipeline includes XmAb819, XmAb541, XmAb808, XmAb942, Plamotamab and XmAb657. The group earns its revenue from collaboration agreements and licensing agreements and operates as a single reportable segment focused on discovering and developing engineered antibody therapeutics to treat patients with cancer and autoimmune diseases who have unmet medical needs.

Share on Social Networks: